Sarah Dixon

Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1988 and is headquartered in Winnersh, the United Kingdom.

CRF Box Oy operates as a software company. It creates electronic clinical outcome assessment (eCOA) solutions. The firm offers project management, scientific support, collaborative design, program management, localization, training and eLearning, and logistic services. The company was founded in 2000 and is headquartered in Helsinki, Finland.

Otsuka Pharmaceutical Europe Ltd. markets drugs, nutraceuticals and other health care products manufactured by its Japan-based parent, Otsuka Pharmaceutical. Some of the company's nutraceutical products include Pocari Sweat-electrolyte replacement beverages, Calorie Mate-energy beverages and the Calcium. Otsuka also makes products for infants under the Bean Stalk name. Additionally, the company conducts pharmaceutical research focusing on gastroenterology, oncology, dermatology, ophthalmology and the cardiovascular system. The company was founded in 1998 and is headquartered in Uxbridge, UK

Part of Clarivate Plc, Centre for Medicines Research International Ltd. is a British company that provides research and development performance metrics to the pharmaceutical industry. The company is based in London, UK. The company was founded in 2001 by Stuart Russel Walker. Centre for Medicines Research International was acquired by Thomson Corp. on April 25, 2006.

CRF, Inc. provides electronic Clinical Outcome Assessment (eCOA) solutions. eCOA encompasses PROs (Patient Reported Outcomes), ObsROs (Observer Reported Outcomes), and ClinROs (Clinician or Rater Reported Outcomes). The firm's platforms include TrialStudio, TrialMax, and TrialManager. The company was founded by Timo Ahopelto, Jarkko Joki-Tokola and Jaakko Ollila in 2000 and is headquartered in Plymouth Meeting, PA.